Drug Profile


Alternative Names: LAS X 113

Latest Information Update: 19 Sep 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Almirall-Prodesfarma
  • Class Antiallergics; Nonsedating antihistamines
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Allergic conjunctivitis; Allergic rhinitis

Most Recent Events

  • 19 Sep 2001 Discontinued-III for Allergic conjunctivitis in Spain (Ophthalmic)
  • 19 Sep 2001 Discontinued-III for Allergic rhinitis in Spain (Intranasal)
  • 15 Feb 1999 Phase-III clinical trials for Allergic conjunctivitis in Spain (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top